Literature DB >> 21692686

The value of N-terminal proB-type natriuretic peptide for early identification of myocardial infarction in patients with high-risk non-ST-elevation acute coronary syndromes.

Robert K Riezebos1, Gerrit J Laarman, Jan G P Tijssen, Freek W A Verheugt.   

Abstract

BACKGROUND: N-terminal proB-type natriuretic peptide (NT-proBNP) is a marker of biomechanical strain, secreted by cardiomyocytes in response to ischemia. As necrosis occurs after prolonged ischemia, a rise in NT-proBNP concentration could precede a rise in markers of necrosis.
METHODS: The aim of the study was to evaluate whether NT-proBNP is able to identify those patients with an evolving myocardial infarction (MI) with high-risk non-ST-elevation acute coronary syndromes (NSTE-ACS). Data were analyzed from a prospective cohort of 103 high-risk NSTE-ACS patients admitted within 6 h after onset of pain and treated with an early invasive strategy. NT-proBNP samples, obtained immediately upon admission, were related to the presence of an in hospital MI. The optimal cut-off value for NT-proBNP was determined using receiver-operating characteristics (ROC) curve analysis.
RESULTS: Analyses was performed separately for creatinine kinase MB-mass (CKMB) and troponin T (TnT) based MI definitions. In both cases, a NT-proBNP concentration above 40 pmol/L (339 ng/L) at admission proved to be independently associated with the presence of MI. The diagnostic odds ratio (OR) for CKMB-MI was 4.9 (confidence interval 2.0-11.9, p<0.001). The diagnostic OR for TnT-MI was 4.9 (1.8-14.4, p=0.003). Adjusting for differences in baseline variables did not weaken the diagnostic OR. In addition, elevated NT-proBNP concentrations were related to unfavour-able demographic, physical and biochemical parameters.
CONCLUSIONS: With a dichotomous cut-off value, a single elevated NT-proBNP (>40 pmol/L) at admission provides independent information about the presence of MI in high-risk NSTE-ACS patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21692686     DOI: 10.1515/CCLM.2011.213

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  2 in total

Review 1.  The role of cardiac biomarkers in the diagnosis and management of patients presenting with suspected acute coronary syndrome.

Authors:  Eric Christenson; Robert H Christenson
Journal:  Ann Lab Med       Date:  2013-08-08       Impact factor: 3.464

2.  The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study.

Authors:  Fang-Yang Huang; Hua Wang; Bao-Tao Huang; Wei Liu; Yong Peng; Chen Zhang; Tian-Li Xia; Peng-Ju Wang; Zhi-Liang Zuo; Yue Heng; Rui-Shuang Liu; Xiao-Bo Pu; Yi-Yue Gui; Shi-Jian Chen; Ye Zhu; Mao Chen
Journal:  Cardiovasc Diabetol       Date:  2016-04-06       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.